BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2279
+0.0077 (3.50%)
Aug 14, 2026, 2:00 PM EDT - Market open
BioRestorative Therapies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.11 | 1.51 | 0.55 | 0.88 | 1.71 | 21.03 |
Short-Term Investments | 0.48 | 1.44 | 10.18 | 10.18 | 13.04 | - |
Cash & Short-Term Investments | 3.59 | 2.95 | 10.73 | 11.07 | 14.75 | 21.03 |
Cash Growth | -60.58% | -72.49% | -3.01% | -24.97% | -29.85% | 586.11% |
Receivables | 0.01 | 0.02 | 0.19 | 0.02 | 0.02 | 0.01 |
Prepaid Expenses | 0.19 | 0.16 | 0.21 | 0.31 | 0.36 | 0.44 |
Other Current Assets | - | 0.01 | 0.01 | - | - | - |
Total Current Assets | 3.8 | 3.14 | 11.14 | 11.39 | 15.13 | 21.47 |
Property, Plant & Equipment | 0.33 | 0.36 | 0.36 | 0.51 | 0.5 | 0.4 |
Other Intangible Assets | 0.51 | 0.53 | 0.62 | 0.71 | 0.8 | 0.59 |
Long-Term Deferred Charges | - | 0.05 | 0.15 | - | - | - |
Total Assets | 4.64 | 4.08 | 12.28 | 12.61 | 16.43 | 22.45 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.67 | 1.34 | 0.48 | 0.19 | 0.17 | 0.05 |
Accrued Expenses | 0.88 | 0.8 | 0.72 | 0.71 | 0.13 | 0.13 |
Short-Term Debt | 0.03 | 0.04 | - | - | - | - |
Current Portion of Long-Term Debt | - | - | - | - | - | 0.06 |
Current Portion of Leases | - | - | - | 0.16 | 0.14 | 0.12 |
Other Current Liabilities | 0.03 | 1.54 | 2.55 | 1.54 | 5.54 | - |
Total Current Liabilities | 1.61 | 3.72 | 3.75 | 2.61 | 5.98 | 0.36 |
Long-Term Debt | - | - | - | - | - | 0.19 |
Long-Term Leases | - | - | - | - | 0.16 | 0.3 |
Total Liabilities | 1.61 | 3.72 | 3.75 | 2.61 | 6.14 | 0.86 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 175.1 | 170.26 | 164.2 | 156.69 | 146.56 | 155.73 |
Retained Earnings | -172.08 | -169.92 | -155.68 | -146.7 | -136.28 | -134.15 |
Total Common Equity | 3.03 | 0.34 | 8.52 | 9.99 | 10.28 | 21.58 |
Shareholders' Equity | 3.03 | 0.36 | 8.53 | 10 | 10.29 | 21.6 |
Total Liabilities & Equity | 4.64 | 4.08 | 12.28 | 12.61 | 16.43 | 22.45 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.03 | 0.04 | - | 0.16 | 0.3 | 0.67 |
Net Cash (Debt) | 3.56 | 2.91 | 10.73 | 10.9 | 14.45 | 20.36 |
Net Cash Growth | -60.90% | -72.88% | -1.57% | -24.53% | -29.03% | - |
Net Cash Per Share | 0.31 | 0.32 | 1.38 | 2.58 | 3.99 | 17.14 |
Filing Date Shares Outstanding | 25.48 | 25.48 | 7.5 | 6.77 | 3.77 | 3.63 |
Total Common Shares Outstanding | 25.48 | 8.88 | 6.92 | 4.71 | 3.68 | 3.52 |
Working Capital | 2.19 | -0.59 | 7.4 | 8.78 | 9.15 | 21.1 |
Book Value Per Share | 0.12 | 0.04 | 1.23 | 2.12 | 2.79 | 6.13 |
Tangible Book Value | 2.51 | -0.19 | 7.89 | 9.28 | 9.47 | 20.99 |
Tangible Book Value Per Share | 0.10 | -0.02 | 1.14 | 1.97 | 2.58 | 5.96 |
Machinery | - | 1.05 | 1 | 0.89 | 0.74 | 0.52 |
Construction In Progress | - | 0.06 | - | - | - | - |
Leasehold Improvements | - | 0.34 | 0.34 | 0.34 | 0.34 | 0.3 |